These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

161 related items for PubMed ID: 10658439

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. [Increasing transcutaneous PO2 in arteriopathies during treatment with PGE1 alpha-cyclodextrin].
    Belcaro G, Cesarone MR.
    Minerva Cardioangiol; 1998 Oct; 46(10 Suppl 1):37-43. PubMed ID: 10658443
    [Abstract] [Full Text] [Related]

  • 3. ["Responders and non-responders" to PGE1 and alpha-cyclodextrin].
    De Sanctis MT, Incandela L, Iacobitti P.
    Minerva Cardioangiol; 1998 Oct; 46(10 Suppl 1):31-6. PubMed ID: 10658442
    [Abstract] [Full Text] [Related]

  • 4. [European trial of PGE1 alpha cyclodextrin. Short-term vs. long-term therapy in intermittent claudication].
    Laurora G, Corsi M, Bucci M, Cesarone MR, Belcaro G, Dugall M.
    Minerva Cardioangiol; 1998 Oct; 46(10 Suppl 1):21-9. PubMed ID: 10658441
    [Abstract] [Full Text] [Related]

  • 5. [Reduction of cardiovascular morbidity/mortality in arteriopathies treated ith PGE1 alpha-cyclodextrin].
    Belcaro G, Bucci M, Cesarone MR, Incandela L, De Sanctis MT.
    Minerva Cardioangiol; 1998 Oct; 46(10 Suppl 1):51-4. PubMed ID: 10658445
    [Abstract] [Full Text] [Related]

  • 6. [Global analysis of data from studies with PDE1 alpha-cyslodextrin].
    Laurora G, Belcaro G, Cesarone MR, Incandela L, De Sanctis MT, Dugall M.
    Minerva Cardioangiol; 1998 Oct; 46(10 Suppl 1):65-8. PubMed ID: 10658448
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. [Intra-arterial infusion of PGE1 alpha cyclodextrin].
    Laurora G, Cesarone MR, Belcaro G, Incandela L, De Sanctis MT, Fascetti E, D'Archivio C.
    Minerva Cardioangiol; 1998 Oct; 46(10 Suppl 1):17-20. PubMed ID: 10658440
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. [Treatment of severe intermittent claudication: ORACLE-PGE1 short term study. A randomised 40-week study. Evaluation of efficacy and costs].
    Cesarone MR, Belcaro G, Nicolaides AN, Griffin M, Geroulakos G, Ramaswami G, Cazaubon M, Barsotti A, Vasdekis S, Christopoulos D, Agus G, Bavera P, Mondani P, Ippolito E, Flenda F.
    Minerva Cardioangiol; 2002 Dec; 50(6):683-90. PubMed ID: 12473989
    [Abstract] [Full Text] [Related]

  • 12. [Intramuscular injections of PGE1 in patients with severe claudication].
    Corsi M, Laurora G, Cesarone MR.
    Minerva Cardioangiol; 1998 Oct; 46(10 Suppl 1):59-63. PubMed ID: 10658447
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.